BELYSSE GROUP NV (BELYS.BR) Stock Fundamental Analysis

EBR:BELYS • BE0974314461

0.765 EUR
+0.01 (+0.66%)
Last: Feb 20, 2026, 05:28 PM
Fundamental Rating

3

Taking everything into account, BELYS scores 3 out of 10 in our fundamental rating. BELYS was compared to 33 industry peers in the Household Durables industry. BELYS has a bad profitability rating. Also its financial health evaluation is rather negative. BELYS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year BELYS has reported negative net income.
  • In the past year BELYS had a positive cash flow from operations.
  • BELYS had negative earnings in 4 of the past 5 years.
  • Of the past 5 years BELYS 4 years had a positive operating cash flow.
BELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFBELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

  • BELYS has a Return On Assets of -0.02%. This is comparable to the rest of the industry: BELYS outperforms 42.42% of its industry peers.
  • BELYS has a Return On Equity of -0.07%. This is comparable to the rest of the industry: BELYS outperforms 42.42% of its industry peers.
  • The Return On Invested Capital of BELYS (6.48%) is better than 69.70% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BELYS is below the industry average of 9.56%.
Industry RankSector Rank
ROA -0.02%
ROE -0.07%
ROIC 6.48%
ROA(3y)-6.3%
ROA(5y)-7.85%
ROE(3y)-25.25%
ROE(5y)-43.19%
ROIC(3y)7.13%
ROIC(5y)5.99%
BELYS.BR Yearly ROA, ROE, ROICBELYS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

  • With a decent Operating Margin value of 6.94%, BELYS is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • BELYS's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 61.34%, BELYS belongs to the top of the industry, outperforming 84.85% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BELYS has remained more or less at the same level.
Industry RankSector Rank
OM 6.94%
PM (TTM) N/A
GM 61.34%
OM growth 3Y-5.23%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
BELYS.BR Yearly Profit, Operating, Gross MarginsBELYS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BELYS is destroying value.
  • BELYS has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, BELYS has an improved debt to assets ratio.
BELYS.BR Yearly Shares OutstandingBELYS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
BELYS.BR Yearly Total Debt VS Total AssetsBELYS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • BELYS has an Altman-Z score of 0.26. This is a bad value and indicates that BELYS is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of BELYS (0.26) is worse than 84.85% of its industry peers.
  • The Debt to FCF ratio of BELYS is 4.98, which is a neutral value as it means it would take BELYS, 4.98 years of fcf income to pay off all of its debts.
  • BELYS's Debt to FCF ratio of 4.98 is fine compared to the rest of the industry. BELYS outperforms 69.70% of its industry peers.
  • A Debt/Equity ratio of 1.80 is on the high side and indicates that BELYS has dependencies on debt financing.
  • BELYS's Debt to Equity ratio of 1.80 is on the low side compared to the rest of the industry. BELYS is outperformed by 87.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 4.98
Altman-Z 0.26
ROIC/WACC0.6
WACC10.86%
BELYS.BR Yearly LT Debt VS Equity VS FCFBELYS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 1.63 indicates that BELYS should not have too much problems paying its short term obligations.
  • With a decent Current ratio value of 1.63, BELYS is doing good in the industry, outperforming 60.61% of the companies in the same industry.
  • BELYS has a Quick Ratio of 1.63. This is a bad value and indicates that BELYS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 0.90, BELYS is doing good in the industry, outperforming 60.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 0.9
BELYS.BR Yearly Current Assets VS Current LiabilitesBELYS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

2

3. Growth

3.1 Past

  • The earnings per share for BELYS have decreased strongly by -100.85% in the last year.
  • BELYS shows a decrease in Revenue. In the last year, the revenue decreased by -6.81%.
  • Measured over the past years, BELYS shows a small growth in Revenue. The Revenue has been growing by 0.43% on average per year.
EPS 1Y (TTM)-100.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100.76%
Revenue 1Y (TTM)-6.81%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.97%

3.2 Future

  • Based on estimates for the next years, BELYS will show a decrease in Earnings Per Share. The EPS will decrease by -1.41% on average per year.
  • BELYS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.36% yearly.
EPS Next Y-70.83%
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%
EPS Next 5YN/A
Revenue Next Year-3.57%
Revenue Next 2Y-0.54%
Revenue Next 3Y0.36%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BELYS.BR Yearly Revenue VS EstimatesBELYS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
BELYS.BR Yearly EPS VS EstimatesBELYS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Forward Earnings ratio of 4.13 indicates a rather cheap valuation of BELYS.
  • Based on the Price/Forward Earnings ratio, BELYS is valued cheaper than 96.97% of the companies in the same industry.
  • BELYS is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.02, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 4.13
BELYS.BR Price Earnings VS Forward Price EarningsBELYS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • BELYS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BELYS is cheaper than 90.91% of the companies in the same industry.
  • BELYS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BELYS is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.87
EV/EBITDA 3.83
BELYS.BR Per share dataBELYS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%

0

5. Dividend

5.1 Amount

  • No dividends for BELYS!.
Industry RankSector Rank
Dividend Yield 0%

BELYSSE GROUP NV

EBR:BELYS (2/20/2026, 5:28:01 PM)

0.765

+0.01 (+0.66%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)10-20
Earnings (Next)03-05
Inst Owners12.65%
Inst Owner ChangeN/A
Ins Owners5.56%
Ins Owner ChangeN/A
Market Cap27.49M
Revenue(TTM)270.29M
Net Income(TTM)-59.00K
Analysts84.44
Price Target1.63 (113.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.13
P/S 0.1
P/FCF 0.87
P/OCF 0.67
P/B 0.34
P/tB N/A
EV/EBITDA 3.83
EPS(TTM)0
EYN/A
EPS(NY)0.19
Fwd EY24.24%
FCF(TTM)0.88
FCFY114.79%
OCF(TTM)1.15
OCFY149.83%
SpS7.52
BVpS2.28
TBVpS-0.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.02%
ROE -0.07%
ROCE 7.91%
ROIC 6.48%
ROICexc 7.66%
ROICexgc 15.72%
OM 6.94%
PM (TTM) N/A
GM 61.34%
FCFM 11.68%
ROA(3y)-6.3%
ROA(5y)-7.85%
ROE(3y)-25.25%
ROE(5y)-43.19%
ROIC(3y)7.13%
ROIC(5y)5.99%
ROICexc(3y)9.09%
ROICexc(5y)7.47%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.69%
ROCE(5y)7.3%
ROICexgc growth 3Y21.04%
ROICexgc growth 5YN/A
ROICexc growth 3Y8.96%
ROICexc growth 5YN/A
OM growth 3Y-5.23%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
F-Score4
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 4.98
Debt/EBITDA 3.8
Cap/Depr 48.2%
Cap/Sales 3.56%
Interest Coverage 1.25
Cash Conversion 106.31%
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 0.9
Altman-Z 0.26
F-Score4
WACC10.86%
ROIC/WACC0.6
Cap/Depr(3y)58.36%
Cap/Depr(5y)60.35%
Cap/Sales(3y)3.69%
Cap/Sales(5y)3.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100.76%
EPS Next Y-70.83%
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.81%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.97%
Revenue Next Year-3.57%
Revenue Next 2Y-0.54%
Revenue Next 3Y0.36%
Revenue Next 5YN/A
EBIT growth 1Y-18.43%
EBIT growth 3Y-4.83%
EBIT growth 5YN/A
EBIT Next Year68.18%
EBIT Next 3Y25.03%
EBIT Next 5YN/A
FCF growth 1Y114.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.99%
OCF growth 3YN/A
OCF growth 5YN/A

BELYSSE GROUP NV / BELYS.BR FAQ

What is the fundamental rating for BELYS stock?

ChartMill assigns a fundamental rating of 3 / 10 to BELYS.BR.


Can you provide the valuation status for BELYSSE GROUP NV?

ChartMill assigns a valuation rating of 5 / 10 to BELYSSE GROUP NV (BELYS.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for BELYSSE GROUP NV?

BELYSSE GROUP NV (BELYS.BR) has a profitability rating of 3 / 10.


What is the financial health of BELYSSE GROUP NV (BELYS.BR) stock?

The financial health rating of BELYSSE GROUP NV (BELYS.BR) is 3 / 10.